Shares of Novartis fell more than 3% on Monday after its cholesterol drug failed in a closely watched study, dealing ‌a blow ...

Developing or continuing to experience heart stress over time is associated with increased risks for cardiovascular disease ...

Novo Nordisk A/S stopped two more trials for its experimental heart disease medicine, in a further blow to the drug’s ...

New 2026 ESC guidelines explain how cardiovascular and kidney disease influence each other and recommend wider kidney ...

The company’s shares declined in after-hours trading after the drug failed to reduce the risk of cardiovascular events in a ...

New ESC guidelines highlight the close connection between heart and kidney health, urging cardiovascular patients to undergo kidney screening and receive timely treatment to reduce serious health ...

Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new ...

Earlier this year, Novo said ziltivekimab failed to reduce the risk of heart attacks and strokes, diminishing expectations ...

Heart disease and kidney disease are closely linked, and kidney damage can remain silent for years. These simple blood, urine ...

While it’s well-known that issues like high blood pressure, diabetes, smoking and not enough exercise are risk factors for a ...

“What we do is we offer structured exercise programmes in community settings to people with diverse chronic illnesses, so we ...

In TODAY.com’s Expert Tip of the Day, a sleep medicine specialist reveals which type of naps could be a “warning sign” and ...